Literature DB >> 670607

Long-term effects of beclomethasone dipropionate on prednisone dosage in the corticosteroid-dependent asthmatic.

E Bacal, R Patterson.   

Abstract

The average prednisone dosage of 54 corticosteroid-dependent asthmatics was computed for one year prior to initiation of beclomethasone dipropionate. This was compared to the average prednisone dosage after nine months on the beclomethasone with progressive tapering of prednisone to either dose compatible with control of asthma or discontinuation. Beclomethasone was found clinically useful in the great majority of these patients because it permitted a significant decrease in dosage of prednisone, a change from daily to alternate-day prednisone, or discontinuation of prednisone after cautious tapering. The first two advantages were most evident in those asthmatics who initially required higher doses of oral steroids while the latter was evident in those requiring lower doses. Those patients whose prednisone dosage does not appear to be beneficially affected by the use of beclomethasone should be suspect as to adherence to proper medical dosage schedule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670607     DOI: 10.1016/0091-6749(78)90081-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Safety and efficacy of long-term treatment with inhaled beclomethasone dipropionate in steroid-dependent asthma.

Authors:  I Broder; S M Tarlo; G M Davies; P Thomas; A Leznoff; J Sturgess; R Baumal; S Mintz; P N Corey
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

2.  Systemic steroids in chronic severe asthma.

Authors:  L D Lewis; G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

Review 3.  Corticosteroids in asthma: inhaled or oral?

Authors:  P W Trembath
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

4.  Should corticosteroid aerosols be used in severe chronic asthma?

Authors:  H Herxheimer
Journal:  Thorax       Date:  1981-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.